0NX Stock Overview
Voxel S.A. operates a network of diagnostic imaging laboratories in Poland.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 3/6 |
| Past Performance | 6/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
Voxel S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | zł20.90 |
| 52 Week High | zł22.40 |
| 52 Week Low | zł9.00 |
| Beta | 0.48 |
| 1 Month Change | -4.57% |
| 3 Month Change | 14.21% |
| 1 Year Change | 125.70% |
| 3 Year Change | 125.70% |
| 5 Year Change | n/a |
| Change since IPO | 117.71% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0NX | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | -0.5% | -1.6% | 1.2% |
| 1Y | 125.7% | -3.9% | 2.0% |
Return vs Industry: 0NX exceeded the German Healthcare industry which returned -3.9% over the past year.
Return vs Market: 0NX exceeded the German Market which returned 2% over the past year.
Price Volatility
| 0NX volatility | |
|---|---|
| 0NX Average Weekly Movement | 4.5% |
| Healthcare Industry Average Movement | 6.2% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 10.1% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: 0NX has not had significant price volatility in the past 3 months.
Volatility Over Time: 0NX's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | 643 | Jaroslaw Furdal | www.voxel.pl |
Voxel S.A. operates a network of diagnostic imaging laboratories in Poland. The company operates in Diagnostics, Therapy, and IT segments. The company provides diagnostic imaging services, which include magnetic resonance imaging scans, computed tomography scans, and positron emission tomography; teleradiology services; and neuroradiosurgery services.
Voxel S.A. Fundamentals Summary
| 0NX fundamental statistics | |
|---|---|
| Market cap | €219.56m |
| Earnings (TTM) | €18.71m |
| Revenue (TTM) | €98.10m |
11.7x
P/E Ratio2.2x
P/S RatioIs 0NX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0NX income statement (TTM) | |
|---|---|
| Revenue | zł424.18m |
| Cost of Revenue | zł283.83m |
| Gross Profit | zł140.35m |
| Other Expenses | zł59.45m |
| Earnings | zł80.89m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 27, 2024
| Earnings per share (EPS) | 7.70 |
| Gross Margin | 33.09% |
| Net Profit Margin | 19.07% |
| Debt/Equity Ratio | 47.1% |
How did 0NX perform over the long term?
See historical performance and comparison